INS and metabolic syndrome: However, the potential neuroprotective effects of metformin have been mostly attributed to its anti-inflammatory and anti-coagulative properties, the prevention of metabolic syndrome (41) and the reduction of peripheral insulin levels that affect brain clearance of amyloid β-peptide (Aβ) (42).